Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.

Postgraduate Medical Journal - United Kingdom
doi 10.1136/pgmj.70.827.651
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Tumour Debulking and Reduction in Predicted Risk of Tumour Lysis Syndrome With Single-Agent Ibrutinib in Patients With Chronic Lymphocytic Leukaemia

British Journal of Haematology
Hematology
2019English

Ochroconis Gallopava Endophthalmitis in Fludarabine Treated Chronic Lymphocytic Leukaemia

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2000English

Venetoclax‐induced Tumour Lysis Syndrome in Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2019English

Prognostic Role of CD4 T-Cell Depletion After Frontline Fludarabine, Cyclophosphamide and Rituximab in Chronic Lymphocytic Leukaemia

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Chronic Lymphocytic Leukaemia

Nature Reviews Disease Primers
Medicine
2017English

Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia

Turkish Journal of Haematology
Hematology
2016English

Waldenström Macroglobulinaemia Terminating in Acute Lymphoblastic Leukaemia After Treatment With Fludarabine

British Journal of Haematology
Hematology
2018English

Treatment Options for High-Risk Chronic Lymphocytic Leukaemia

Therapeutic Advances in Hematology
Hematology
2011English

Acute Renal Failure With Chronic Lymphocytic Leukaemia.

Postgraduate Medical Journal
Medicine
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy